Skip to main content
Contact Us
Subscribe
E-Edition
76°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Rallybio Corporation - Common Stock
(NQ:
RLYB
)
0.4117
-0.0347 (-7.77%)
Streaming Delayed Price
Updated: 10:04 AM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rallybio Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 09, 2025
Via
Benzinga
Top movers in Tuesday's session
July 08, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Most active stocks in Tuesday's session
July 08, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.
Via
Chartmill
Here's Why Shares in Recursion Pharmaceuticals Surged Today
July 08, 2025
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 08, 2025
Via
Benzinga
What's going on in today's session
July 08, 2025
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
Gapping stocks in Tuesday's session
July 08, 2025
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
July 08, 2025
Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments.
Via
Benzinga
Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals
July 08, 2025
From
Rallybio Corporation
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
June 30, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 13, 2025
Via
Benzinga
Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
June 12, 2025
From
Rallybio Corporation
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 04, 2025
Via
Benzinga
Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates
May 08, 2025
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference
April 29, 2025
From
Rallybio Corporation
Via
Business Wire
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
April 15, 2025
Via
Benzinga
Which stocks have an unusual volume on Monday?
April 14, 2025
Unusual volume stocks are being observed in Monday's session.
Via
Chartmill
This PTC Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
April 09, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 08, 2025
Via
Benzinga
Rallybio Stock Plunges After Program For Pediatric Bleeding Disorder Disappoints
April 08, 2025
Rallybio ends RLYB212 trial for FNAIT; shifts focus to RLYB116 and preclinical assets with 2025 trial milestones and $6 billion market potential.
Via
Benzinga
Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT
April 08, 2025
From
Rallybio Corporation
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 18, 2025
Via
Benzinga
Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
March 13, 2025
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the TD Cowen 45th Annual Health Care Conference
February 25, 2025
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial
February 11, 2025
From
Rallybio Corporation
Via
Business Wire
Rallybio Highlights 2024 Accomplishments and Anticipated Milestones for 2025
January 10, 2025
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting
December 10, 2024
From
Rallybio Corporation
Via
Business Wire
Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025
December 02, 2024
From
Rallybio Corporation
Via
Business Wire
Rallybio Announces Publication of Target-Mediated Drug Disposition Modeling and Simulations Informing the RLYB212 Dosing Regimen in Pregnant Women
November 27, 2024
From
Rallybio Corporation
Via
Business Wire
Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference
November 26, 2024
From
Rallybio Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.